AU2002366756A1 - Use of benzofuroxan derivatives as antiplatelet agents - Google Patents

Use of benzofuroxan derivatives as antiplatelet agents

Info

Publication number
AU2002366756A1
AU2002366756A1 AU2002366756A AU2002366756A AU2002366756A1 AU 2002366756 A1 AU2002366756 A1 AU 2002366756A1 AU 2002366756 A AU2002366756 A AU 2002366756A AU 2002366756 A AU2002366756 A AU 2002366756A AU 2002366756 A1 AU2002366756 A1 AU 2002366756A1
Authority
AU
Australia
Prior art keywords
antiplatelet agents
benzofuroxan derivatives
benzofuroxan
derivatives
antiplatelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366756A
Inventor
Alangudi Sankaranarayanan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002366756A1 publication Critical patent/AU2002366756A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002366756A 2001-12-20 2002-12-13 Use of benzofuroxan derivatives as antiplatelet agents Abandoned AU2002366756A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34128301P 2001-12-20 2001-12-20
US60/341,283 2001-12-20
PCT/IB2002/005353 WO2003053439A1 (en) 2001-12-20 2002-12-13 Use of benzofuroxan derivatives as antiplatelet agents

Publications (1)

Publication Number Publication Date
AU2002366756A1 true AU2002366756A1 (en) 2003-07-09

Family

ID=23336943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366756A Abandoned AU2002366756A1 (en) 2001-12-20 2002-12-13 Use of benzofuroxan derivatives as antiplatelet agents

Country Status (2)

Country Link
AU (1) AU2002366756A1 (en)
WO (1) WO2003053439A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2515413C2 (en) * 2012-07-05 2014-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) 1,2,5-oxadiazole derivatives, having anti-hiv activity, pharmaceutical composition, method of inhibiting hiv-1 integrase
CN114920722B (en) * 2021-06-02 2024-03-08 何黎琴 7-hydroxy-3-acetyl coumarin oxime compound, preparation method and medical application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
DE4218977A1 (en) * 1992-06-10 1993-12-16 Cassella Ag Annellated 1,2,5-oxadiazole-2-oxides
DE4220264A1 (en) * 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazole-carbonamide-2-oxide
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses
IN188837B (en) * 1998-05-22 2002-11-09 Torrent Pharmaceuticals Ltd

Also Published As

Publication number Publication date
WO2003053439A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
AU2002352142A1 (en) Pyrazolopyridine derivatives
AU2002314252A1 (en) Chemical derivatives and the use thereof as an anti-telomerase agent
AU2002347336A1 (en) Quinoline derivatives
AU2002251140A1 (en) Chemical derivatives and their use as anti-telomerase agent
AU2002347359A1 (en) Quinoline derivatives
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2002366756A1 (en) Use of benzofuroxan derivatives as antiplatelet agents
AU2002332178A1 (en) Benzimidazole derivatives
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2002229859A1 (en) Chemical derivatives and their use as anti-telomerase agent
HK1053059A1 (en) New use of imidazotriazinon derivatives
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002255261A1 (en) Novel use of arylethenessulfonamide derivatives
PL347345A1 (en) Non-ionic derivatives of bisalkanoyl bisglucamines
AU2002328933A1 (en) Use of soraphen derivatives
AU2003274043A1 (en) Novel use of dioxocin-5-on derivatives
AU2002354910A1 (en) Antifungal agents of sordarin derivatives
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
GB0109520D0 (en) Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as njk-inhibitors
AU2002317000A1 (en) Morpholine-bridged pyrazolopyridine derivatives
AU2002337340A1 (en) Antimicrobial use of anhydrofructose derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase